Medistim
Price
Price
CHART BY
Historical dividends and forecast
Medistim has so far distributed $0.864 in 2026. The next dividend will be paid on 18.05.2027
CHART BY
Frequently asked questions
What is Medistim's market capitalization?
What is Medistim's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Medistim?
What are the analyst ratings and target price for Medistim's stock?
What is Medistim's revenue over the trailing twelve months?
What is the EBITDA for Medistim?
What is the free cash flow of Medistim?
How many employees does Medistim have, and what sector and industry does it belong to?
What is the free float of Medistim's shares?
Financials
- Market Cap
- NOK 4.10B
- EPS (TTM)
- $8.542
- Free Float
- 12.98M
- P/E ratio (TTM)
- 26.22
- Revenue (TTM)
- NOK 719.89M
- EBITDA (TTM)
- NOK 219.59M
- Free Cashflow (TTM)
- NOK 175.49M
Pricing
- 1D span
- $24.05$24.57
- 52W span
- $18.44$29.26
Analyst Ratings
The price target is NOK 286.67 and the stock is covered by 3 analysts.
Buy
2
Hold
1
Sell
0
Information
Medistim ASA engages in the development, manufacture, and distribution of medical equipment and consumables. It operates through the Own Products and Third Party Products segments. The Own Products segment leases and sells equipment. The Third Party Products segment markets medical devices purchased from third party manufacturers located in Denmark and Norway. Its products include MiraQ Cardiac, MiraQ Vascular, MiraQ Ultimate, Imaging Probe, and Flow Probe. The company was founded by Kari Mette Tjolsen Pah on June 10, 1984 and is headquartered in Oslo, Norway.
- Employees
- 159
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- NO0010159684
- Primary Ticker
- MEDI